Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Genvec Inc (GNVC)

Genvec Inc (GNVC)
7.19 -0.02 (-0.28%) 06/15/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Thu, Jun 15th, 2017
Day Low
7.01
Day High
7.25
Open 7.21
Previous Close 7.21 7.21
Volume 12,900 12,900
Avg Vol 9,680 9,680
Stochastic %K 96.96% 96.96%
Weighted Alpha -26.60 -26.60
5-Day Change +0.46 (+6.84%) +0.46 (+6.84%)
52-Week Range 2.70 - 10.44 2.70 - 10.44
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,321
  • Shares Outstanding, K 2,270
  • Annual Sales, $ 510 K
  • Annual Income, $ -5,790 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 3.34
  • Price/Sales 32.08
  • Price/Cash Flow N/A
  • Price/Book 28.20
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.65
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.00 +19.83%
on 05/31/17
Period Open: 7.64
7.75 -7.23%
on 05/16/17
-0.45 (-5.89%)
since 05/15/17
3-Month
5.44 +32.17%
on 04/06/17
Period Open: 6.43
7.97 -9.79%
on 05/15/17
+0.76 (+11.82%)
since 03/15/17
52-Week
2.70 +166.30%
on 11/01/16
Period Open: 6.00
10.44 -31.13%
on 01/10/17
+1.19 (+19.83%)
since 06/15/16

Business Summary

GenVec, Inc. is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of the Company's product candidates uses patent-protected technology to deliver genes that produce beneficial proteins. GenVec's lead product, TNFerade is currently in a pivotal Phase II/III study...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 7.39
1st Resistance Point 7.29
Last Price 7.19
1st Support Level 7.05
2nd Support Level 6.91
3rd Support Level N/A

See More

52-Week High 10.44
Fibonacci 61.8% 7.48
Last Price 7.19
Fibonacci 50% 6.57
Fibonacci 38.2% 5.66
52-Week Low 2.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar